1. Home
  2. CNNE vs ASMB Comparison

CNNE vs ASMB Comparison

Compare CNNE & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CNNE

Cannae Holdings Inc.

HOLD

Current Price

$12.86

Market Cap

497.5M

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$30.00

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CNNE
ASMB
Founded
2014
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
497.5M
440.0M
IPO Year
2017
2010

Fundamental Metrics

Financial Performance
Metric
CNNE
ASMB
Price
$12.86
$30.00
Analyst Decision
Buy
Strong Buy
Analyst Count
3
5
Target Price
$21.33
$44.20
AVG Volume (30 Days)
678.8K
70.0K
Earning Date
05-11-2026
05-07-2026
Dividend Yield
4.73%
N/A
EPS Growth
N/A
91.78
EPS
N/A
N/A
Revenue
$499,700,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$235.63
P/E Ratio
N/A
N/A
Revenue Growth
3.37
N/A
52 Week Low
$10.46
$9.68
52 Week High
$21.96
$39.71

Technical Indicators

Market Signals
Indicator
CNNE
ASMB
Relative Strength Index (RSI) 63.53 56.00
Support Level $11.54 $29.31
Resistance Level $16.41 $30.54
Average True Range (ATR) 0.46 1.44
MACD 0.24 0.14
Stochastic Oscillator 97.40 82.49

Price Performance

Historical Comparison
CNNE
ASMB

About CNNE Cannae Holdings Inc.

Cannae Holdings Inc is an investment holding company that acquires and actively manages equity interests in operating businesses across various industries. The Company focuses on long-term ownership and seeks to create value by supporting the growth and operations of its portfolio companies through management expertise and strategic oversight. The Company operates through four reportable segments: Restaurant Group, which includes the operations of O'Charleys and 99 Restaurants; Alight, which represents its ownership interest in a technology-enabled human capital and employee benefits solutions provider; Black Knight Football Club (BKFC), which holds interests in professional football clubs; and JANA, which represents its investment in an investment management firm.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: